Welcome to LookChem.com Sign In|Join Free

CAS

  • or

120077-69-2

Post Buying Request

120077-69-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

120077-69-2 Usage

General Description

4-Bromo-3-chloro-benzaldehyde is a chemical compound with the molecular formula C7H4BrClO. It is a pale yellow to beige solid that is used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. 4-BROMO-3-CHLORO-BENZALDEHYDE is primarily used as a building block in the production of various chemicals, including agrochemicals, plant growth regulators, and pharmaceuticals. It is also used in the synthesis of fine chemicals and has applications in research and development. 4-Bromo-3-chloro-benzaldehyde is a versatile and important chemical reagent that finds use in a wide range of industries.

Check Digit Verification of cas no

The CAS Registry Mumber 120077-69-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,0,7 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 120077-69:
(8*1)+(7*2)+(6*0)+(5*0)+(4*7)+(3*7)+(2*6)+(1*9)=92
92 % 10 = 2
So 120077-69-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrClO/c8-6-2-1-5(4-10)3-7(6)9/h1-4H

120077-69-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Bromo-3-chlorobenzaldehyde

1.2 Other means of identification

Product number -
Other names 4-bromo-3-chlorobenzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:120077-69-2 SDS

120077-69-2Relevant articles and documents

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

-

Paragraph 00695, (2017/08/01)

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

FATTY ACID SYNTHASE INHIBITORS

-

Page/Page column 97, (2014/01/18)

This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

Chemical subtleties in small-molecule modulation of peptide receptor function: The case of CXCR3 biaryl-type ligands

Wijtmans, Maikel,Scholten, Danny J.,Roumen, Luc,Canals, Meritxell,Custers, Hans,Glas, Marjolein,Vreeker, Marlies C.A.,De Kanter, Frans J.J.,De Graaf, Chris,Smit, Martine J.,De Esch, Iwan J.P.,Leurs, Rob

supporting information, p. 10572 - 10583 (2013/02/22)

The G protein-coupled chemokine receptor CXCR3 plays a role in numerous inflammatory events. The endogenous ligands for the chemokine receptors are peptides, but in this study we disclose small-molecule ligands that are able to activate CXCR3. A class of biaryl-type compounds that is assembled by convenient synthetic routes is described as a new class of CXCR3 agonists. Intriguingly, structure-activity relationship and structure-function relationship studies reveal that subtle chemical modifications on the outer aryl ring (e.g., either the size or position of a halogen atom) result in a full spectrum of agonist efficacies on CXCR3. Quantum mechanics calculations and nuclear Overhauser effect spectroscopy NMR studies suggest that the biaryl dihedral angle and the electronic nature of ortho-substituents play an important role in determining agonist efficacies. Compounds 38 (VUF11222) and 39 (VUF11418) are the first reported nonpeptidomimetic agonists on CXCR3, rendering them highly useful chemical tools for detailed assessment of CXCR3 activation as well as for studying downstream CXCR3 signaling.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 120077-69-2